Therapy of invasive infections due to multidrug-resistant Enterobacteriaceae (MDR-E) is
challenging, and some of the few active drugs are not available in many countries. For …

The worldwide spread of extended-spectrum β-lactamase (ESBL)-producing bacteria,
particularly Escherichia coli and Klebsiella pneumoniae, is a critical concern for the …

Scope These ESCMID guidelines address the targeted antibiotic treatment of third-
generation cephalosporin-resistant Enterobacterales (3GCephRE) and carbapenem …

Extended spectrum β-lactamase (ESBL)-producing bacteria are prevalent worldwide and
correlated with hospital infections, but they have been evolving as an increasing cause of …

Acute leukemias are a group of aggressive malignant diseases associated with a high
degree of morbidity and mortality. An important cause of both the latter is infectious …

Background Bacteremia caused by extended-spectrum β-lactamase (ESBL)-producing
Enterobacteriaceae (ESBL-E) is associated with inadequate empirical therapy and …

Background Infections due to extended-spectrum beta-lactamase (ESBL)-producing
Enterobacteriaceae pose a major public health threat due to poor outcomes and high …

Introduction: Infections are among the most frequent complications in patients with
hematological and oncological diseases. They might be classified as fever of unknown …

Febrile neutropenia is a common complication in patients with hematologic malignancies
receiving chemotherapy, and is associated with high morbidity and mortality. Infections …

Abstract Objectives Bloodstream infections (BSIs) caused by extended-spectrum beta-
lactamase-producing Enterobacteriaceae (ESBL-PE) have become a worldwide public …